DESIGN, OPTIMIZATION, AND EVALUATION OF RAFT FORMING GASTRO RETENTIVE DRUG DELIVERY SYSTEM OF LAFUTIDINE USINGBOX–BEHNKEN DESIGN

LANKALAPALLI SRINIVAS; SHANTI SAGAR

doi:10.22159/ijap.2022v14i1.43358

Authors

LANKALAPALLI SRINIVAS Department of Pharmaceutics, GITAM Institute of Pharmacy, GITAM (Deemed To Be University), Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India https://orcid.org/0000-0002-6918-8297
SHANTI SAGAR Department of Pharmaceutics, GITAM Institute of Pharmacy, GITAM (Deemed To Be University), Rushikonda, Visakhapatnam 530045, Andhra Pradesh, India

DOI:

https://doi.org/10.22159/ijap.2022v14i1.43358

Keywords:

Lafutidine, Anti-ulcer, Gastro-retentive, Box–Behnken design (BBD), Buoyancy lag-time, Zero-order release

Abstract

Objective: The current research was aimed to formulate and evaluate raft forming gastro retentive floating drug delivery systems of Lafutidine for improving gastric residence time and sustained drug release for an extended time.

Methods: Using Box–Behnken experimental design 17 formulations of lafutidine GRDDS were designed and evaluated for various parameters like physical appearance, pH, In vitro gelling study, in vitro buoyancy study, measurement of viscosity, density measurement, gel strength, drug content, acid neutralization capacity, the profile of neutralization, in vitro dissolution, release kinetic and stability studies.

Results: All the evaluations were performed and observed that the values were within range, and the buoyancy lag time ranged within 14.76 to 25.84 sec and the formulations remained buoyant for more than 8h with the gelling time of 12h, the drug content was ranging from 98.96 to 99.55 %, and in vitro release was 86.86 to 99.34% by the end of 12h. The release kinetics followed zero-order with Higuchi’s model that indicating that drug release was found to be followed by the matrix diffusion process.

Conclusion: Out of all formulations F3 was the optimized formulation and it was further characterized for FTIR, DSC, and stability studies, which exposed that there were no interactions amongst drug and excipients and no major change in the formulation and found to be stable.

Downloads

Download data is not yet available.

References

Kagan L, Hoffman A. Selection of drug candidates for gastroretentive dosage forms: pharmacokinetics following continuous intragastric mode of administration in a rat model. Eur J Pharm Biopharm. 2008 May;69(1):238-46. doi: 10.1016/j.ejpb.2007.10.019, PMID 18068342.

Reddy BV, Navaneetha K, Sandeep P, Deepthi A. Gastroretentive drug delivery system-a review. J Glob Trends Pharm Sci. 2013;4(1):1018-33.

Hasan MJ, Kamal BA. Formulation and evaluation of ranitidine hydrochloride as floating in situ gel. Int J Pharm Pharm Sci. 2014;6:401-5.

Hampson FC, Farndale A, Strugala V, Sykes J, Jolliffe IG, Dettmar PW. Alginate rafts and their characterisation. Int J Pharm. 2005 Apr 27;294(1-2):137-47. doi: 10.1016/j.ijpharm.2005.01.036, PMID 15814238.

Pawar AY, Jadhav KR, Nikam MN. A raft forming system: a novel approach for gastroretention. Int J Pure Appl Biosci. 2015;3(4):178-92.

Parveen A, Reddy RS. Formulation and in vitro evaluation of gastroretentive bilayer floating tablets of clarithromycin and lafutidine. Int J Pharm Technol. 2014;6:6651-70.

Lolitas D, Kumar DM, Rao H. Design and evaluation of lafutidine floating tablets for controlled release by using semi-synthetic and natural polymer. J Drug Discov Ther. 2014;24:2.

Ranch KM, Maulvi FA, Naik MJ, Koli AR, Parikh RK, Shah DO. Optimization of a novel in situ gel for sustained ocular drug delivery using box-behnken design: in vitro, ex vivo, in vivo and human studies. Int J Pharm. 2019;554:264-75. doi: 10.1016/j.ijpharm.2018.11.016. PMID 30423418.

Abou Youssef NA, Kassem AA, El-Massik MA, Boraie NA. Development of gastroretentive metronidazole floating raft system for targeting helicobacter pylori. Int J Pharm. 2015;486(1-2):297-305. doi: 10.1016/j.ijpharm.2015.04.004, PMID 25843757.

Abouelatta SM, Aboelwafa AA, El-Gazayerly ON. Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug. Drug Deliv. 2018 Nov;25(1):1161-74. doi: 10.1080/10717544.2018.1474969, PMID 29792353.

Abbas G, Hanif M, Khan MA. pH responsive alginate polymeric rafts for controlled drug release by using box behnken response surface design. Des Monomers Polym. 2017;20(1):1-9. doi: 10.1080/15685551.2016.1231046, PMID 29491774.

Abbas G, Hanif M, Shah S, Zaman M. Raft-forming system for pantoprazole and domperidone delivery: in vitro and in vivo study. Bioinsp Biomimetic Nano Biomat. 2019:1-10.

Pasa G, Choudhury PK, Panigrahi G, Maharana B. Formulation design and optimization of floating matrix tablets of ciprofloxacin HCl by using HPMC and ethyl cellulose with experimental design. IJPSDR. 2019;11(1):7-15. doi: 10.25004/IJPSDR.2019.110102.

Pashikanti S, BJ. Formulation and evaluation of floating in situ gel of ciprofloxacin. Int J Appl Pharm 2019;11(1):198. doi: 10.22159/ijap.2019v11i1.28603.

Sindhoor SM, Priya S. Maxwell a formulation and evaluation of novel in situ gel of lafutidine for gastroretentive drug delivery. Asian J Pharm Clin Res. 2018;11(8):88-94.

Patel DM, Patel GD, Patel NC. Formulation and optimization of raft forming chewable tablet containing lafutidine. Int J Pharm Sci Drug Res. 2015 May 7;3:229-34.

Rapolu K, Sanka K, Vemula PK, Aatipamula V, Mohd AB, Diwan PV. Optimization and characterization of gastroretentive floating drug delivery system using box-behnken design. Drug Dev Ind Pharm. 2013 Dec;39(12):1928-35. doi: 10.3109/03639045.2012.699068, PMID 22762132.

Rosa MJ, Zia H, Rhodes TC. Design and testing in vitro of bioadhesive and floating drug delivery system oral application. Int J Pharm. 1994;105:65-70.

Jang SW, Lee JW, Ryu DS, Son M, Kang MJ. Design of pH-responsive alginate raft formulation of risedronate for reduced esophageal irritation. Int J Biol Macromol. 2014 Sep;70:174-8. doi: 10.1016/j.ijbiomac.2014.06.048, PMID 24995633.

Alhamdany AT, Abbas AK. Formulation and in vitro evaluation of amlodipine gastroretentive floating tablets using a combination of hydrophilic and hydrophobic polymers. Int J Appl Pharm. 2018;10(6):119-25. doi: 10.22159/ijap.2018v10i6.28687.

Hanif M, Abbas G. pH-responsive alginate-pectin polymeric rafts and their characterization. Adv Polym Technol. 2018;37(5):1496-506. doi: 10.1002/adv.21808.

Senjoti GF, Jaffri MJ, Manda KU. Fabrication and optimization of gastro retentive drug delivery system with HPMC and polyethylene oxide (PEO) matrix. International Conference on Pharmaceutical Sciences and Biomedical and Chemical Engineering. Kuantan, Malaysia: Kulliyyah of Pharmacy International Islamic University Malaysia (IIUM); 2014. p. 113-7.

Sriamornsak P, Thirawong N, Weerapol Y, Nunthanid J, Sungthongjeen S. Swelling and erosion of pectin matrix tablets and their impact on drug release behavior. Eur J Pharm Biopharm. 2007;67(1):211-9. doi: 10.1016/j.ejpb.2006.12.014, PMID 17267193.